Melittin's biological activity has made it a focus in drug discovery, particularly in oncology and antimicrobial research.

In the mellitin reagent market, drug discovery is the largest application, and interest is growing. Melittin can disrupt cell membranes, which is being explored for targeted cancer therapies. It also shows antimicrobial properties, relevant as antibiotic resistance rises.

Researchers use melittin reagents to study membrane interactions, test delivery systems, and evaluate therapeutic potential. Derivatives are being developed to improve stability and reduce toxicity.

Challenges include toxicity to healthy cells and delivery complexity. Nanotechnology and targeted delivery systems are being explored to address these issues.

Clinical translation remains early-stage, but the research pipeline is expanding. For reagent suppliers, this means growing demand for high-purity products and validated assays.

People Also Ask

• Q: Is melittin used in cancer treatment?
  A: It is being researched for anticancer applications, though clinical use remains limited.

• Q: What challenges limit melittin use?
  A: Toxicity and delivery challenges are the main barriers.

Tags: melittin, cancer research, drug discovery, antimicrobial peptides, therapeutic development